PATHOPHYSIOLOGY OF FIBRINOLYSIS

被引:19
作者
JUHANVAGUE, I [1 ]
ALESSI, MC [1 ]
DECLERCK, PJ [1 ]
机构
[1] FAC PHARM LOUVAIN, PHARMACEUT BIOL & PHYTOPHARMACOL LAB, B-3000 LOUVAIN, BELGIUM
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1995年 / 8卷 / 02期
关键词
D O I
10.1016/S0950-3536(05)80271-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The observed association between abnormal fibrinolysis and a tendency toward bleeding or thrombosis demonstrates the (patho)physiological importance of the fibrinolytic system. Deficient fibrinolysis representents an important haemostatic abnormality associated with thrombosis. A decreased fibrinolytic activity may be due to a defective synthesis and/or release of tissue-type plasminogen activator (t-PA) from the vessel wall, to a deficiency or functional defect in the plasminogen or fibrinogen molecule or more frequently to increased levels of t-PA inhibitor. Alternatively, excessive fibrinolysis due to increased levels of t-PA, to α2-antiplasmin deficiency or to plasminogen activator inhibitor-1 (PAI-1) deficiency, may result in bleeding tendency. © 1995 Baillière Tindall. All rights reserved.
引用
收藏
页码:329 / 343
页数:15
相关论文
共 109 条
  • [81] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    RIDKER, PM
    VAUGHAN, DE
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    [J]. LANCET, 1993, 341 (8854) : 1165 - 1168
  • [82] PROSPECTIVE-STUDY OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR AND RISK OF STROKE
    RIDKER, PM
    HENNEKENS, CH
    STAMPFER, MJ
    MANSON, JE
    VAUGHAN, DE
    [J]. LANCET, 1994, 343 (8903) : 940 - 943
  • [83] ROBBINS KC, 1991, THROMB HAEMOSTASIS, V66, P575
  • [84] ROCHA E, 1988, THROMB HAEMOSTASIS, V59, P93
  • [85] SAKATA Y, 1980, J BIOL CHEM, V255, P5442
  • [86] SAMAMA M, 1980, SYNTHETIC SUBSTRATES, P93
  • [87] SCHARRER IM, 1986, THROMB HAEMOSTASIS, V55, P396
  • [88] BLEEDING DIATHESIS DUE TO DECREASED FUNCTIONAL-ACTIVITY OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    SCHLEEF, RR
    HIGGINS, DL
    PILLEMER, E
    LEVITT, LJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) : 1747 - 1752
  • [89] ATTENUATED FIBRINOLYSIS AND ACCELERATED ATHEROGENESIS IN TYPE-II DIABETIC-PATIENTS
    SCHNEIDER, DJ
    NORDT, TK
    SOBEL, BE
    [J]. DIABETES, 1993, 42 (01) : 1 - 7
  • [90] INCREASED TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR GENE-EXPRESSION IN ATHEROSCLEROTIC HUMAN ARTERIES
    SCHNEIDERMAN, J
    SAWDEY, MS
    KEETON, MR
    BORDIN, GM
    BERNSTEIN, EF
    DILLEY, RB
    LOSKUTOFF, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 6998 - 7002